Key Points
- Agilent VP Rodney Gonsalves sold 3,000 shares on Nov. 26 at an average price of $154.99 for about $464,970, trimming his stake by 8.61% to 31,846 shares (≈$4.94M).
- Agilent slightly beat Q3 estimates with $1.59 EPS vs. $1.58 and $1.86B revenue, issued Q1 and FY2026 guidance, and raised its quarterly dividend to $0.255 (annualized $1.02, 0.7% yield); analysts carry a "Moderate Buy" consensus with an average target near $161.08.
Agilent Technologies, Inc. (NYSE:A - Get Free Report) VP Rodney Gonsalves sold 3,000 shares of the company's stock in a transaction dated Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the completion of the transaction, the vice president owned 31,846 shares of the company's stock, valued at approximately $4,935,811.54. This trade represents a 8.61% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.
Agilent Technologies Stock Performance
A opened at $150.08 on Tuesday. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The business's 50 day moving average is $142.91 and its 200-day moving average is $127.15. The stock has a market cap of $42.55 billion, a PE ratio of 35.23, a price-to-earnings-growth ratio of 4.67 and a beta of 1.29. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $160.27.
Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.58 by $0.01. The business had revenue of $1.86 billion during the quarter, compared to analyst estimates of $1.83 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business's revenue for the quarter was up 9.4% compared to the same quarter last year. During the same period in the prior year, the company posted $1.46 EPS. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS. FY 2026 guidance at 5.860-6.000 EPS. On average, analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.
Agilent Technologies Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 28th. Stockholders of record on Tuesday, January 6th will be issued a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. This is a positive change from Agilent Technologies's previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Tuesday, January 6th. Agilent Technologies's dividend payout ratio is 22.32%.
Institutional Trading of Agilent Technologies
A number of hedge funds and other institutional investors have recently made changes to their positions in A. Brighton Jones LLC grew its position in Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock worth $626,000 after buying an additional 270 shares during the last quarter. Cetera Investment Advisers boosted its stake in shares of Agilent Technologies by 8.1% during the 1st quarter. Cetera Investment Advisers now owns 36,267 shares of the medical research company's stock worth $4,243,000 after acquiring an additional 2,723 shares in the last quarter. LPL Financial LLC grew its holdings in shares of Agilent Technologies by 3.8% in the 1st quarter. LPL Financial LLC now owns 121,147 shares of the medical research company's stock worth $14,172,000 after acquiring an additional 4,468 shares during the last quarter. Federated Hermes Inc. raised its position in shares of Agilent Technologies by 3.7% during the first quarter. Federated Hermes Inc. now owns 34,226 shares of the medical research company's stock worth $4,004,000 after purchasing an additional 1,218 shares during the period. Finally, Alberta Investment Management Corp lifted its holdings in shares of Agilent Technologies by 263.9% during the first quarter. Alberta Investment Management Corp now owns 30,200 shares of the medical research company's stock valued at $3,533,000 after purchasing an additional 21,900 shares during the last quarter. 87.41% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several equities research analysts recently weighed in on the stock. TD Cowen upped their price objective on shares of Agilent Technologies from $150.00 to $162.00 and gave the stock a "buy" rating in a report on Tuesday, October 14th. Wall Street Zen upgraded shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Friday, October 3rd. Wells Fargo & Company increased their price objective on shares of Agilent Technologies from $150.00 to $175.00 and gave the company an "overweight" rating in a report on Tuesday, November 25th. Rothschild & Co Redburn initiated coverage on shares of Agilent Technologies in a research note on Wednesday, October 8th. They set a "buy" rating and a $165.00 price objective on the stock. Finally, Citigroup upped their target price on Agilent Technologies from $165.00 to $185.00 and gave the stock a "buy" rating in a research report on Tuesday, November 25th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, Agilent Technologies has an average rating of "Moderate Buy" and an average price target of $161.08.
Read Our Latest Research Report on A
About Agilent Technologies
(
Get Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
